What is Amgen's finished goods?

Amgen (AMGN) reported finished goods of $1.71B in Q1 2026.

How has Amgen's finished goods changed year-over-year?

Amgen's finished goods decreased by 11.2% year-over-year, from $1.93B to $1.71B.

What is the long-term trend for Amgen's finished goods?

Over 5 years (2020 to 2025), Amgen's finished goods has grown at a 14.2% compound annual growth rate (CAGR), from $970M to $1.89B.

Current Assets

Finished goods

Amgen Finished goods decreased by 9.2% to $1.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.2%, from $1.93B to $1.71B. Over 5 years (FY 2020 to FY 2025), Finished goods shows an upward trend with a 14.2% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2015

Last reportedQ1 2026Apr 30, 2026

Parent metricInventories

Metric ID: inv_finished_goods

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$1.03B	$1.17B	$1.07B	$1.08B	$1.01B	$1.03B	$1B	$1.13B	$1.08B	$1.19B	$2.78B	$2.53B	$2.64B	$2.24B	$2.06B	$1.93B	$2.04B	$1.84B	$1.89B	$1.71B
QoQ Change	—	+13.7%	-8.5%	+0.7%	-6.2%	+1.5%	-2.2%	+12.5%	-4.9%	+10.2%	+134.4%	-9.1%	+4.3%	-15.2%	-7.8%	-6.5%	+5.9%	-10.0%	+2.7%	-9.2%
YoY Change	—	—	—	—	-1.8%	-12.4%	-6.3%	+4.7%	+6.2%	+15.4%	+176.7%	+123.5%	+145.1%	+88.6%	-25.8%	-23.7%	-22.6%	-17.9%	-8.5%	-11.2%
% of Inventories	25.1%	28.2%	26.2%	24.5%	22.2%	21.6%	20.4%	22.6%	21.6%	23.6%	29.2%	29.0%	33.0%	30.4%	29.4%	28.6%	31.0%	28.9%	30.3%	27.7%
Share Change	—	+3.2pp	-2.0pp	-1.8pp	-2.2pp	-0.6pp	-1.2pp	+2.2pp	-1.0pp	+2.0pp	+5.6pp	-0.2pp	+4.0pp	-2.6pp	-0.9pp	-0.8pp	+2.4pp	-2.1pp	+1.3pp	-2.6pp

Range$1B – $2.78B

CAGR+11.3%

Avg YoY Growth+26.9%

Median YoY Growth-4.1%

Finished goods at Other Companies

Eli LillyLLY View metric

Merck & Co.MRK View metric

ALN

Alnylam PharmaceuticalsALNY View metric

BiogenBIIB View metric

IncyteINCY View metric

Frequently Asked Questions

What is Amgen's finished goods?: Amgen (AMGN) reported finished goods of $1.71B in Q1 2026.
How has Amgen's finished goods changed year-over-year?: Amgen's finished goods decreased by 11.2% year-over-year, from $1.93B to $1.71B.
What is the long-term trend for Amgen's finished goods?: Over 5 years (2020 to 2025), Amgen's finished goods has grown at a 14.2% compound annual growth rate (CAGR), from $970M to $1.89B.